Cutaneous Leishmaniasis
📧 Sign up to get email alerts when something new happens for Cutaneous Leishmaniasis.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2019-02-15Clinical Trial Update: Efficacy and Safety of Pentamidine (7mg/kg) for Patients With Cutaneous Leishmaniasis Caused by L. Guyanensis [Phase 2]
Phase 2 trial evaluating the efficacy and safety of pentamidine at 7 mg/kg for cutaneous leishmaniasis caused by Leishmania guyanensis; the …
-
CLINICAL_TRIALS trial_result · 2019-01-22Clinical Trial Update: Topical Treatment of Recalcitrant Ulcerative Old World Leishmaniasis With WR 279,396 [Phase 2]
Phase 2 clinical trial of a topical WR 279,396 for recalcitrant Old World cutaneous leishmaniasis was terminated with results posted.
-
CLINICAL_TRIALS trial_result · 2019-01-16Clinical Trial Update: Effectiveness, Safety and Feasibility of HECT-CL, in Quetta, Pakistan [Phase 3]
A Phase 3 clinical trial evaluating HECT-CL for cutaneous leishmaniasis in Quetta, Pakistan has been terminated.
-
CLINICAL_TRIALS trial_result · 2018-02-27Clinical Trial Update: Miltefosine Plus IL Pentamidine for Bolivian CL [Phase 2]
Phase 2 trial evaluating miltefosine in combination with intralesional pentamidine for cutaneous leishmaniasis in Bolivia has completed.
-
CLINICAL_TRIALS trial_result · 2017-09-26Clinical Trial Update: Fourth-generation Immucillin Derivative DI4G Associated Therapy in Cutaneous Leishmaniasis [Phase 2]
Phase 2 clinical trial update for a fourth-generation Immucillin derivative (DI4G) associated therapy in cutaneous leishmaniasis has complet…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2017-08-23Clinical Trial Update: Phase 3 Study of Walter Reed (WR) 279,396 and Paromomycin Alone for the Treatment of Cutaneous Leishmaniasis in Panama [Phase 3]
Phase 3 study evaluating Walter Reed (WR) 279,396 and paromomycin alone for cutaneous leishmaniasis completed with results posted.
-
CLINICAL_TRIALS trial_result · 2017-08-08Clinical Trial Update: Accuracy of a Rapid Diagnostic Test for Cutaneous Leishmaniasis in Morocco
The document reports the completed clinical trial evaluating the accuracy of a rapid diagnostic test for cutaneous leishmaniasis in Morocco.
-
CLINICAL_TRIALS trial_result · 2017-07-14Clinical Trial Update: Local Heat Therapy Versus Sodium Stibogluconate for the Treatment of Cutaneous Leishmaniasis [Phase 2]
Phase 2 trial comparing local heat therapy to sodium stibogluconate for cutaneous leishmaniasis has completed with posted results.
-
CLINICAL_TRIALS trial_result · 2017-06-20Clinical Trial Update: Evaluation of a Rapid Diagnostic Device, CL Detect, for the Diagnosis of Cutaneous Leishmaniasis in Tunisia
A completed clinical trial evaluated the rapid diagnostic device CL Detect for diagnosing cutaneous leishmaniasis in Tunisia. Results of the…
-
CLINICAL_TRIALS trial_result · 2017-02-15Clinical Trial Update: Topical Treatment of Cutaneous Leishmaniasis With WR 279,396: A Phase 2 Study in the Old World [Phase 2]
A Phase 2 clinical trial evaluating topical WR-279,396 for cutaneous leishmaniasis has been completed, with results posted in 2017.
-
CLINICAL_TRIALS trial_result · 2017-01-26Clinical Trial Update: Antimony Plus Pentoxifylline in Cutaneous Leishmaniasis [Phase 2, Phase 3]
A Phase 2/3 trial evaluating antimony in combination with pentoxifylline for cutaneous leishmaniasis has completed.
-
CLINICAL_TRIALS trial_result · 2017-01-25Clinical Trial Update: WR 279,396 for the Treatment of Cutaneous Leishmaniasis [Phase 2]
This is an update on a Phase 2 trial evaluating WR 279,396 for cutaneous leishmaniasis. The study status is completed.
-
CLINICAL_TRIALS research · 2017-01-04Clinical Trial Update: Fractional CO2 Laser With Topical Pentostam Treatment for Cutaneous Leishmaniasis. [NA]
This clinical trial update describes a study evaluating the combination of fractional CO2 laser energy with topical sodium stibogluconate (P…
-
CLINICAL_TRIALS trial_result · 2016-08-23Clinical Trial Update: Add-on Study of Pentoxifylline in Cutaneous Leishmaniasis [Phase 2, Phase 3]
The document notes the completion of a Phase 2/3 add-on clinical trial evaluating pentoxifylline for cutaneous leishmaniasis.
-
CLINICAL_TRIALS trial_result · 2016-08-22Clinical Trial Update: Pharmacokinetics of Miltefosine in Children and Adults [Phase 4]
This update summarizes a Phase 4 pharmacokinetic study of miltefosine in children and adults with cutaneous leishmaniasis.
-
CLINICAL_TRIALS trial_result · 2016-07-26Clinical Trial Update: Topical 3% Amphotericin B Cream for the Treatment of Cutaneous Leishmaniasis in Colombia [Phase 1, Phase 2]
Clinical trial update indicating completion of Phase 1/Phase 2 testing of a topical 3% amphotericin B cream for Cutaneous Leishmaniasis in C…
-
FDA approval · 2016-01-04FDA Approved: IMPAVIDO — Supplemental Application (Profounda, Inc.)
FDA approved a supplemental application for IMPAVIDO (miltefosine) from Profounda, Inc. under NDA204684, expanding its approved use. This ac…
-
CLINICAL_TRIALS trial_result · 2016-01-01Clinical Trial Update: Cosmetic Outcome of Leishmaniasis Scar After WR279396 Application [NA]
The update reports cosmetic outcomes of Leishmaniasis scars after topical WR279396 in a completed clinical trial.
-
CLINICAL_TRIALS trial_result · 2015-12-02Clinical Trial Update: High Dose Fluconazole in Cutaneous Leishmaniasis in Bahia and Manaus [Phase 3]
Phase 3 trial of high-dose fluconazole for cutaneous leishmaniasis has been terminated.
-
CLINICAL_TRIALS trial_result · 2014-12-19Clinical Trial Update: WR 279,396 Open Label Treatment Protocol in Tunisia [Phase 2]
Phase 2 open-label study of WR 279,396 for cutaneous leishmaniasis in Tunisia was terminated, with results posted in December 2014.
-
CLINICAL_TRIALS research · 2014-11-03Clinical Trial Update: Prospective Observational Study of Intralesional Treatment With Pentostam in Cutaneous Leishmaniasis Israeli Patients
Prospective observational study evaluating intralesional Pentostam for cutaneous leishmaniasis in Israeli patients; the trial status is unkn…
-
CLINICAL_TRIALS trial_result · 2014-10-17Clinical Trial Update: Safety and Efficacy of Azithromycin to Treat Cutaneous Leishmaniasis [Phase 2, Phase 3]
This clinical trial update indicates the Phase 2/Phase 3 study evaluating azithromycin for treating Cutaneous Leishmaniasis has been termina…
-
CLINICAL_TRIALS trial_result · 2014-08-22Clinical Trial Update: Safety, Efficacy and Pharmacokinetics (PK) Study of WR 279,396 Versus Paromomycin for Treatment of Cutaneous Leishmaniasis (Peru-PK) [Phase 2]
Phase 2 study comparing WR-279,396 to paromomycin for cutaneous leishmaniasis evaluating safety, efficacy, and pharmacokinetics; results hav…
-
CLINICAL_TRIALS trial_result · 2014-07-14Clinical Trial Update: Phase 3 Study to Evaluate WR 279,396 vs. Paromomycin Alone to Treat Cutaneous Leishmaniasis (in Tunisia) [Phase 3]
Phase 3 study comparing WR 279,396 to paromomycin alone for cutaneous leishmaniasis completed; results posted in 2014.
-
CLINICAL_TRIALS trial_result · 2014-05-15Clinical Trial Update: Pharmacokinetics, Safety, and Efficacy Trial of WR 279,396 (Paromomycin + Gentamicin Topical Cream) and Paromomycin Topical Cream for the Treatment of Cutaneous Leishmaniasis in Panama [Phase 2]
Phase 2 trial evaluating pharmacokinetics, safety, and efficacy of WR 279,396 (paromomycin + gentamicin topical cream) and paromomycin topic…